WP1

Lead Beneficiary: UFZ / Berger
Co-lead : UvA / Droge
Duration: Months 1 – 48

Objectives

i) To develop and apply novel analytical techniques that can be used to detect, identify and quantify a wide range of PFASs in human matrices and relevant exposure media, including total organofluorine approaches, ii) to improve the understanding of human exposure pathways (including air, diet, drinking water, dermal, consumer products etc.) to legacy and previously unidentified PFASs.